Live Breaking News & Updates on Clinical research dalarna

Time to Add aHSCT to Standard Care in RRMS?

73% of patients with relapsing remitting multiple sclerosis were disease free 5 years after aHSCT treatment, and more than half reported improved disability.

Sweden , Stockholm , Uppsala , Uppsala-lan , Dalarna , Kopparberg , Swedish , Joachim-burman , Clinical-research-dalarna , Swedish-research-council , Marcus-wallenberg-foundation , Regional-research-council